ÂÜÀòÂÒÂ×

Imran Hamid is Senior Investment Principal, responsible for both leading new investments and managing existing portfolio companies.

Imran has over 15 years of biopharma, digital health, and med-tech experience with a career spanning clinical practice, strategy, entrepreneurship, M&A, R&D, and venture to invest.

Prior to joining LifeArc, Imran was Senior Director of New Ventures and Transactions at Johnson & Johnson Innovation, Director of Business Development and Licensing at Mallinckrodt, and Director of Commercial Discovery at Merck & Co.

Imran received his medical degree from Imperial College London, where he graduated with joint honors from the Imperial College Business School. He is a member of the Royal College of Surgeons.